RankAlpha logo
Back to Rankings

OPCH

Option Care HealthB
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-08-03
View Chart
Current thesis
The constructive view is that OPCH still has national scale, acute therapy growth, maintained 2026 adjusted EPS/EBITDA guidance, and added liquidity via an $850M revolver, so the post-earnings selloff may have over-discounted a therapy-mix issue rather than a full-franchise impairment.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -6.2.
What can break
Chief Growth Officer Christopher L. Grashoff is departing effective May 8, 2026, increasing scrutiny on commercial execution during a growth slowdown. [#8-K-2026-05-05]
Momentum
22
Value
65
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $30.00 · Bear $17.00
Data freshness
Prices
As of 2026-08-03
Fundamentals
As of 2026-07-31 • Vendor: Data Vendor v1
Scores
As of 2026-08-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-06 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-08-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $28.58
Why
Momentum22 · Δ7d +7.6
Value65 · Δ7d -0.5
Sentiment54 · Δ7d -6.2
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
22
10% active weight
Current posture
7d trendImproving
Δ7d
+7.6
Δ21d
+3.3
Value
65
40% active weight
Current posture
7d trendFlat
Δ7d
-0.5
Δ21d
-0.9
Sentiment
54
49% active weight
Current posture
7d trendSoftening
Δ7d
-6.2
Δ21d
-11.6
Why this grade

Composite grade B. Momentum 22.4 / Value 64.7 / Sentiment 54.5

Fundamentals (TTM)
As of 2026-07-31
Market Cap
$3.62B
Beta
0.84
Shares Out
157.03M
P/E (TTM)
25.5
P/S (TTM)
0.92
P/FCF (TTM)
23.15
Rev YoY
+1.3%
EPS YoY
+2.3%
Gross Margin
+18.0%
Op Margin
+6.0%
Net Debt
$1.04B
Current Ratio
1.64
As of 2026-08-03 • Updated nightlySource: Internal modelMethodology